Stanley J. Schmidt

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess et al. · ACS Medicinal Chemistry Letters · 2010 · 367 citations · Full text

Highly Potent Inhibitor, Tumor Biology, Mammalian Target +16

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier et al. · Nature Chemical Biology · 2015 · 174 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme

Roland E. Dolle, C. V. C. Prasad, Stanley J. Schmidt et al. · Journal of Medicinal Chemistry · 1994 · 146 citations

Interleukin-1.beta.-converting Enzyme, Immunology, Altmetric Attention Score +18

Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase

Nicholas D. Adams, Jerry L. Adams, Joelle L. Burgess et al. · Journal of Medicinal Chemistry · 2010 · 108 citations · Full text

Aurora B/c Kinase, Chemoprevention Strategy, Molecular Biology +21

Palladium catalysed alkoxycarbonylation of phenols to benzoate esters

Roland E. Dolle, Stanley J. Schmidt, Lawrence I. Kruse · Journal of the Chemical Society Chemical Communications · 1987 · 98 citations

Cross-coupling Reaction, Engineering, Spectra-structure Correlation +9